Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced-Dose Radiotherapy with Chemotherapy for Standard Risk Adult Medulloblastoma
NCT01857453Phase 2Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Apr 2013
- Primary completion
- Dec 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, etoposide in medulloblastoma, sponsored by CHRU de Nancy - Hôpital Central. Status: unknown.
02
Drugs
carboplatinetoposide
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT01857453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857453.